Sangamo Therapeutics ROA 2006-2018 | SGMO

Current and historical return on assets (ROA) values for Sangamo Therapeutics (SGMO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Sangamo Therapeutics ROA for the three months ending September 30, 2018 was -13.93%.
Sangamo Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.06B $0.61B -13.98%
2018-06-30 $-0.06B $0.63B -16.92%
2018-03-31 $-0.06B $0.28B -20.34%
2017-12-31 $-0.05B $0.29B -21.88%
2017-09-30 $-0.05B $0.27B -23.78%
2017-06-30 $-0.06B $0.28B -30.81%
2017-03-31 $-0.07B $0.15B -44.85%
2016-12-31 $-0.07B $0.16B -41.08%
2016-09-30 $-0.08B $0.17B -40.00%
2016-06-30 $-0.07B $0.18B -31.88%
2016-03-31 $-0.05B $0.20B -23.26%
2015-12-31 $-0.04B $0.22B -17.41%
2015-09-30 $-0.03B $0.23B -12.70%
2015-06-30 $-0.03B $0.23B -12.10%
2015-03-31 $-0.02B $0.24B -9.80%
2014-12-31 $-0.03B $0.24B -10.83%
2014-09-30 $-0.03B $0.25B -13.85%
2014-06-30 $-0.03B $0.25B -14.72%
2014-03-31 $-0.03B $0.26B -17.68%
2013-12-31 $-0.03B $0.14B -24.13%
2013-09-30 $-0.02B $0.14B -22.52%
2013-06-30 $-0.02B $0.07B -26.67%
2013-03-31 $-0.02B $0.08B -26.91%
2012-12-31 $-0.02B $0.08B -25.81%
2012-09-30 $-0.03B $0.08B -28.99%
2012-06-30 $-0.03B $0.09B -33.05%
2012-03-31 $-0.03B $0.09B -36.57%
2011-12-31 $-0.04B $0.09B -44.44%
2011-09-30 $-0.04B $0.09B -50.67%
2011-06-30 $-0.04B $0.10B -53.24%
2011-03-31 $-0.03B $0.05B -48.82%
2010-12-31 $-0.03B $0.06B -35.71%
2010-09-30 $-0.02B $0.07B -25.00%
2010-06-30 $-0.02B $0.07B -20.76%
2010-03-31 $-0.02B $0.08B -23.53%
2009-12-31 $-0.02B $0.09B -29.92%
2009-09-30 $-0.02B $0.05B -34.04%
2009-06-30 $-0.02B $0.06B -32.94%
2009-03-31 $-0.02B $0.06B -33.33%
2008-12-31 $-0.02B $0.07B -32.88%
2008-09-30 $-0.03B $0.07B -36.36%
2008-06-30 $-0.03B $0.08B -32.20%
2008-03-31 $-0.02B $0.08B -32.65%
2007-12-31 $-0.02B $0.08B -31.34%
2007-09-30 $-0.02B $0.09B -38.33%
2007-06-30 $-0.02B $0.05B -41.51%
2007-03-31 $-0.02B $0.05B -35.40%
2006-12-31 $-0.02B $0.06B -32.88%
2006-09-30 $-0.01B $0.06B -22.64%
2006-06-30 $-0.01B $0.06B -29.05%
2006-03-31 $-0.01B $0.04B -35.86%
2005-12-31 $-0.01B $0.05B -42.42%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.890B $0.037B
Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Biogen (BIIB) United States $65.504B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $47.772B 63.99
Regeneron Pharmaceuticals (REGN) United States $45.961B 21.35
Illumina (ILMN) United States $44.432B 52.84
Alexion Pharmaceuticals (ALXN) United States $28.812B 17.86
Incyte (INCY) United States $17.998B 168.16
BioMarin Pharmaceutical (BMRN) United States $16.355B 0.00
Seattle Genetics (SGEN) United States $11.263B 0.00
Exact Sciences (EXAS) United States $10.517B 0.00
Sarepta Therapeutics (SRPT) United States $9.373B 0.00
QIAGEN (QGEN) Netherlands $8.817B 28.83
Alnylam Pharmaceuticals (ALNY) United States $8.541B 0.00
BeiGene (BGNE) Cayman Islands $8.254B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.417B 0.00
Bio-Techne Corp (TECH) United States $7.246B 48.82
Moderna (MRNA) United States $6.852B 0.00
Exelixis (EXEL) United States $6.383B 14.93
Amarin (AMRN) Ireland $5.664B 0.00
Alkermes (ALKS) Ireland $5.319B 0.00
Galapagos (GLPG) Belgium $5.211B 0.00
Array BioPharma (ARRY) United States $5.041B 0.00
Guardant Health (GH) United States $4.307B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.052B 0.00
Allogene Therapeutics (ALLO) United States $3.872B 0.00
Horizon Pharma Public (HZNP) Ireland $3.800B 15.63
Intercept Pharmaceuticals (ICPT) United States $3.486B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.372B 0.00
Emergent Biosolutions (EBS) United States $3.345B 28.18
Blueprint Medicines (BPMC) United States $3.303B 0.00
Ascendis Pharma (ASND) Denmark $2.993B 0.00
Genomic Health (GHDX) United States $2.985B 100.78
ACADIA Pharmaceuticals (ACAD) United States $2.874B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.873B 0.00
Immunomedics (IMMU) United States $2.725B 0.00
China Biologic Products (CBPO) China $2.666B 18.98
Global Blood Therapeutics (GBT) United States $2.649B 0.00
Repligen (RGEN) United States $2.610B 81.52
Reata Pharmaceuticals (RETA) United States $2.565B 0.00
Ligand Pharmaceuticals (LGND) United States $2.524B 18.13
Mirati Therapeutics (MRTX) United States $2.467B 0.00
Arena Pharmaceuticals (ARNA) United States $2.451B 0.00
Halozyme Therapeutics (HALO) United States $2.431B 54.26
Akcea Therapeutics (AKCA) United States $2.322B 0.00
Myriad Genetics (MYGN) United States $2.307B 23.49
Amicus Therapeutics (FOLD) United States $2.194B 0.00
Denali Therapeutics (DNLI) United States $2.039B 0.00
Insmed (INSM) United States $2.031B 0.00
Acceleron Pharma (XLRN) United States $1.948B 0.00
Spark Therapeutics (ONCE) United States $1.929B 0.00
Atara Biotherapeutics (ATRA) United States $1.838B 0.00
Medicines (MDCO) United States $1.813B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.785B 0.00
AnaptysBio (ANAB) United States $1.767B 0.00
MyoKardia (MYOK) United States $1.749B 0.00
NeoGenomics (NEO) United States $1.696B 139.62
CRISPR Therapeutics AG (CRSP) Switzerland $1.682B 0.00
REGENXBIO (RGNX) United States $1.677B 22.50
Zai Lab Unsponsored ADR (ZLAB) China $1.664B 0.00
Myovant Sciences (MYOV) United Kingdom $1.504B 0.00
Allakos (ALLK) United States $1.474B 0.00
Innoviva (INVA) United States $1.468B 4.05
UniQure (QURE) Netherlands $1.432B 0.00
ALECTOR INC (ALEC) United States $1.417B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.384B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.384B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.373B 0.00
Aimmune Therapeutics (AIMT) United States $1.351B 0.00
Cambrex (CBM) United States $1.289B 13.89
Clovis Oncology (CLVS) United States $1.285B 0.00
Lion Biotechnologies (IOVA) United States $1.260B 0.00
GOSSAMER BIO (GOSS) United States $1.243B 0.00
Codexis (CDXS) United States $1.178B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.123B 0.00
WAVE Life Sciences (WVE) Singapore $1.113B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.103B 0.00
Audentes Therapeutics (BOLD) United States $1.068B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.056B 42.85
Rubius Therapeutics (RUBY) United States $1.049B 0.00
Puma Biotechnology (PBYI) United States $1.027B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.013B 0.00
Editas Medicine (EDIT) United States $0.967B 0.00
Epizyme (EPZM) United States $0.964B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.955B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.951B 0.00
Coherus BioSciences (CHRS) United States $0.938B 0.00
Fate Therapeutics (FATE) United States $0.932B 0.00
Retrophin (RTRX) United States $0.871B 0.00
Athenex (ATNX) United States $0.858B 0.00
Vericel (VCEL) United States $0.838B 0.00
CytomX Therapeutics (CTMX) United States $0.818B 0.00
Apellis Pharmaceuticals (APLS) United States $0.808B 0.00
Novavax (NVAX) United States $0.800B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.787B 0.00
InflaRx (IFRX) Germany $0.772B 0.00
G1 THERAPEUTICS (GTHX) United States $0.765B 0.00
Heska (HSKA) United States $0.749B 61.26
Cellectis (CLLS) France $0.746B 0.00
Principia Biopharma (PRNB) United States $0.745B 0.00
Intra-Cellular Therapies (ITCI) United States $0.740B 0.00
ANI Pharmaceuticals (ANIP) United States $0.720B 13.77
Arvinas (ARVN) United States $0.715B 0.00
Dynavax Technologies (DVAX) United States $0.688B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.674B 0.00
Cara Therapeutics (CARA) United States $0.664B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.651B 0.00
Acorda Therapeutics (ACOR) United States $0.647B 8.40
Viking Therapeutics (VKTX) United States $0.645B 0.00
RA PHARMCTL INC (RARX) United States $0.632B 0.00
Twist Bioscience (TWST) United States $0.621B 0.00
Synthorx (THOR) United States $0.599B 0.00
Intellia Therapeutics (NTLA) United States $0.595B 0.00
Kura Oncology (KURA) United States $0.580B 0.00
Anika Therapeutics (ANIK) United States $0.568B 23.53
Lexicon Pharmaceuticals (LXRX) United States $0.562B 0.00
UROGEN PHARMA (URGN) Israel $0.556B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.553B 0.00
Osiris Therapeutics (OSIR) United States $0.547B 0.00
Eidos Therapeutics (EIDX) United States $0.530B 0.00
Prothena (PRTA) Ireland $0.530B 0.00
Arcus Biosciences (RCUS) United States $0.498B 0.00
UNITY Biotechnology (UBX) $0.497B 0.00
Zymeworks (ZYME) Canada $0.495B 0.00
PDL BioPharma (PDLI) United States $0.495B 8.07
ProQR Therapeutics (PRQR) Netherlands $0.484B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.471B 0.00
Zealand Pharma (ZEAL) Denmark $0.462B 5.09
DBV Technologies (DBVT) France $0.451B 0.00
Senesco Technologies (ELOX) United States $0.448B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.445B 0.00
Scholar Rock Holding (SRRK) United States $0.439B 0.00
ObsEva SA (OBSV) Switzerland $0.437B 0.00
Replimune (REPL) United States $0.429B 0.00
Cytokineticsorporated (CYTK) United States $0.421B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.415B 0.00
Five Prime Therapeutics (FPRX) United States $0.414B 0.00
OSMOTICA PHARM (OSMT) United States $0.412B 0.00
Kezar Life Sciences (KZR) United States $0.411B 0.00
BeyondSpring (BYSI) United States $0.402B 0.00
Mesoblast (MESO) Australia $0.396B 0.00
Agenus (AGEN) United States $0.380B 0.00
MediciNova (MNOV) United States $0.375B 0.00
AVROBIO (AVRO) United States $0.371B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.370B 0.00
Sinovac Biotech (SVA) China $0.369B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.367B 0.00
Stemline Therapeutics (STML) United States $0.367B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Cellular Biomedicine (CBMG) United States $0.364B 0.00
Inovio Pharmaceuticals (INO) United States $0.352B 0.00
MeiraGTx Holdings (MGTX) United States $0.351B 0.00
BioDelivery Sciences (BDSI) United States $0.341B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.338B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.329B 0.00
Urovant Sciences (UROV) United States $0.327B 0.00
Abeona Therapeutics (ABEO) United States $0.320B 0.00
Albireo Pharma (ALBO) United States $0.312B 0.00
Evelo Biosciences (EVLO) United States $0.309B 0.00
Aduro Biotech (ADRO) United States $0.308B 0.00
XBiotech (XBIT) United States $0.308B 0.00
Enochian BioSciences (ENOB) United States $0.296B 0.00
Magenta Therapeutics (MGTA) United States $0.294B 0.00
Geron (GERN) United States $0.291B 0.00
Solid Biosciences (SLDB) United States $0.291B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.282B 0.00
Intec Pharma (NTEC) Israel $0.280B 0.00
Constellation Pharmaceuticals (CNST) United States $0.279B 0.00
Sorrento Therapeutics (SRNE) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.266B 0.00
AC Immune SA (ACIU) Switzerland $0.264B 0.00
Merus (MRUS) Netherlands $0.263B 0.00
Kala Pharmaceuticals (KALA) United States $0.261B 0.00
Axsome Therapeutics (AXSM) United States $0.256B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.253B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.252B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Celcuity (CELC) United States $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.245B 0.00
Verastem (VSTM) United States $0.244B 0.00
MannKind (MNKD) United States $0.238B 0.00
Synlogic (SYBX) United States $0.237B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Kamada (KMDA) Israel $0.235B 10.60
ResTORbio (TORC) United States $0.233B 0.00
Liquidia Technologies (LQDA) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Adverum Biotechnologies (ADVM) United States $0.232B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.232B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
TOCAGEN INC (TOCA) United States $0.217B 0.00
Athersys (ATHX) United States $0.215B 0.00
ChromaDex (CDXC) United States $0.213B 0.00
Arbutus Biopharma (ABUS) Canada $0.209B 0.00
Cerecor (CERC) United States $0.209B 0.00
LogicBio Therapeutics (LOGC) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.206B 0.00
Celyad SA (CYAD) Belgium $0.203B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.203B 0.00
CorMedix Inc (CRMD) United States $0.200B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
Axovant Sciences (AXGT) United Kingdom $0.187B 0.00
Aptinyx (APTX) United States $0.186B 0.00
ADMA Biologics Inc (ADMA) United States $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Protagonist Therapeutics (PTGX) United States $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.174B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Menlo Therapeutics (MNLO) United States $0.166B 0.00
BioTime (BTX) United States $0.161B 0.00
Palatin Technologies (PTN) United States $0.161B 79.24
VBI Vaccines (VBIV) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.156B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Proteostasis Therapeutics (PTI) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.149B 0.00
OvaScience (MLND) United States $0.146B 0.00
Allena Pharmaceuticals (ALNA) United States $0.146B 0.00
BioXcel Therapeutics (BTAI) United States $0.138B 0.00
Cohbar (CWBR) United States $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.132B 0.00
Pfenex (PFNX) United States $0.130B 0.00
Cue Biopharma (CUE) United States $0.129B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.125B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
Trevena (TRVN) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.122B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.122B 0.00
Equillium (EQ) United States $0.120B 0.00
XOMA (XOMA) United States $0.119B 0.00
Pluristem Therapeutics (PSTI) Israel $0.118B 0.00
Mustang Bio (MBIO) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
VolitionRX (VNRX) Singapore $0.101B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.092B 0.00
NantKwest (NK) United States $0.090B 0.00
Signal Genetics (MGEN) United States $0.089B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cel-Sci (CVM) United States $0.082B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
Orgenesis (ORGS) United States $0.080B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.079B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
PHASEBIO PHARMA (PHAS) United States $0.077B 0.00
Protalix BioTherapeutics (PLX) Israel $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
Alimera Sciences (ALIM) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.073B 0.00
INMUNE BIO INC (INMB) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Idera Pharmaceuticals (IDRA) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
AEterna Zentaris (AEZS) United States $0.067B 12.75
Celldex Therapeutics (CLDX) United States $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
OVID THERAPEUTC (OVID) United States $0.063B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.063B 0.00
Evogene (EVGN) Israel $0.061B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
ARAVIVE, INC (ARAV) United States $0.059B 5.15
Proteon Therapeutics (PRTO) United States $0.058B 0.00
VIVUS (VVUS) United States $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Ophthotech (OPHT) United States $0.056B 0.00
ScPharmaceuticals (SCPH) United States $0.054B 0.00
Asterias Biotherapeutics (AST) United States $0.053B 0.00
Vaccinex (VCNX) United States $0.053B 0.00
Alcobra (ARCT) United States $0.052B 0.00
Entera Bio (ENTX) Israel $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Eyenovia (EYEN) United States $0.050B 0.00
Bellerophon Therapeutics (BLPH) United States $0.047B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.044B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.039B 0.00
Arsanis (ASNS) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Curis (CRIS) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Sophiris Bio (SPHS) United States $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.033B 5.31
Motif Bio Plc (MTFB) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
TRACON Pharmaceuticals (TCON) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
AZURRX BIOPHARM (AZRX) United States $0.029B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Oragenics (OGEN) United States $0.027B 0.00
Zosano Pharma (ZSAN) United States $0.027B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Adial Pharmaceuticals (ADIL) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Vical (VICL) United States $0.022B 0.00
GTx (GTXI) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Soligenix (SNGX) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.49
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.014B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Neuralstem (CUR) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00